Stronger Together Psoriatic Arthritis Wellness Study

Patients diagnosed with psoriatic arthritis (PsA) confront decisions about how to treat their disease, interact with their health care providers, and modify lifestyle choices that may improve treatment outcomes. With sponsorship support from Janssen and in partnership with the Cleveland Clinic, this survey study will seek to understand and examine whether people living with PsA are interested in and motivated to participate in wellness activities. This cross-sectional observational survey study will help researchers and clinicians to better understand what some of the barriers and facilitators experienced by patients are when considering participation in guided online wellness activities.

People that qualify for the study and complete a 10-minute survey will be invited to participate in Immune Strength, an online wellness program developed by the Cleveland Clinic. Immune Strength is a free 10-week program for creating better habits for a more resilient immune system. By following this program, participants will have the opportunity to learn about how to develop strategies and implement behavior changes for healthier immune functioning.

Participants will be recruited by the Global Healthy Living Foundation (GHLF). GHLF is the parent organization of the CreakyJoints® (CJ) arthritis patient community and primary site for the PCORI-funded Arthritis Patient Partnership with Comparative Effectiveness Researchers (AR-PoWER) Patient Powered Research Network (PPRN), known as ArthritisPower®. ArthritisPower is a subset of CreakyJoints members who have expressed interest in participating in research and signed an informed consent form to participate in the PPRN and its associated research. Any individuals recruited from CreakyJoints or Facebook, who are not already members of ArthritisPower will be encouraged to join the ArthritisPower registry research app, but will not be required to do so in order to participate in the study.

Study Overview

• Status: Recruiting
• Conditions: Psoriatic Arthritis
• Intervention / Treatment: Behavioral: Immune Strength

• Study Type: Observational
• Enrollment (Estimated): 100

Contacts and Locations

• Study Contact: Name: Shilpa Venkatachalam, Phd; Phone Number: (845) 348 0400; Email: svenky@ghlf.org
• Study Contact Backup: Name: Laura Stradford, MPH; Phone Number: (845) 348 0400; Email: lstradford@ghlf.org

Study Locations

• United States
  • New York
    • Upper Nyack, New York, United States, 10960
      • Recruiting
      • Global Healthy Living Foundation
      • Contact: Shilpa Venkatachalam, Phd; Phone Number: (845) 348 0400; Email: svenky@ghlf.org
      • Contact: Ben Nowell, Phd; Phone Number: 845-348-0400; Email: bnowell@ghlf.org

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 19 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: N/A

• Sampling Method: Non-Probability Sample

Study Population

Participants will be recruited by the Global Healthy Living Foundation (GHLF). GHLF is the parent organization of the CreakyJoints® (CJ) arthritis patient community and primary site for PatientSpot Patient Powered Research Network (PPRN), known as PatientSpot®. PatientSpot is a subset of CreakyJoints members who have expressed interest in participating in research and signed an informed consent form to participate in the PPRN and its associated research. Any individuals recruited from CreakyJoints or Facebook, who are not already members of PatientSpot will be encouraged to join the PatientSpot registry research app, but will not be required to do so in order to participate in the study.

Description

Inclusion Criteria:

• Participants must be residents of the United States and United States territories
• Participants must be age 19 and above for United States resident or 21 and above for Puerto Rico residents
• Participants must have a self-reported diagnosis of psoriatic arthritis (PsA) (as indicated by survey screening questions)
• Participants must be taking prescribed medication to treat their PsA
• Participants must have access to a computer or smartphone to take the survey

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Particpants; participating in Immune Strength, a multi-week wellness program	Behavioral: Immune Strength; Multi-week wellness program provided by the Cleveland Clinic

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Barriers to Wellness	Percent of participants that experience barriers in using wellness to help manage their disease	Day 1
Interest in Wellness Programs	Percent of participants interested in participating in a wellness program to complement treatment for controlling their disease	Day 1

Collaborators and Investigators

• Sponsor: Global Healthy Living Foundation
• Collaborators: The Cleveland Clinic

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2022
• Primary Completion (Estimated): March 1, 2026
• Study Completion (Estimated): March 1, 2026

Study Registration Dates

• First Submitted: December 7, 2022
• First Submitted That Met QC Criteria: December 7, 2022
• First Posted (Actual): December 15, 2022

Study Record Updates

• Last Update Posted (Actual): September 26, 2024
• Last Update Submitted That Met QC Criteria: September 25, 2024
• Last Verified: September 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Skin Diseases; Joint Diseases; Musculoskeletal Diseases; Skin Diseases, Papulosquamous; Spinal Diseases; Bone Diseases; Spondylarthropathies; Spondylarthritis; Spondylitis; Psoriasis; Arthritis; Arthritis, Psoriatic
• Other Study ID Numbers: Pro00062932

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No